Home >> News >> Business >> Electronic Batch Record (EBR) Software Market is set to register double digit growth over the forecast period 2017 to 2025

Electronic Batch Record (EBR) Software Market is set to register double digit growth over the forecast period 2017 to 2025

According to a new market research report published by Credence Research “Electronic Batch Record Software Market (Deployment Model – On-premise and Hosted; End-user – Pharmaceuticals, Biotechnology, Food & Beverages, Chemicals & Polymers, Consumer Products and Others (Oil & Gas, Automobile etc.)) – Growth, Future Prospects and Competitive Analysis, 2017 – 2025”, the global electronic batch records (EBR) software market is set to register double digit growth over the forecast period 2017 to 2025.

The purpose of the report is to illustrate the state of the market of Sterile Injectables, to present actual information about the volumes of production, exports, imports, consumption and the state of the market, the changes that took place in 2017, and also, to build a forecast for the growth of the industry in the medium term until 2026.

Browse here for full report: https://www.credenceresearch.com/report/electronic-batch-record-ebr-software-market

Market Insights

Pharmaceuticals and biotechnology are among the industry verticals bound by stringent regulations enforced across manufacturing as well as research and development. Very few industries are required to maintain such high level of process accountability, transparency and control as compared to that followed by the pharmaceuticals industry. As part of these regulations (e.g. U.S. FDA 21 CFR Part 11), pharmaceutical companies are required to maintain records of each product being manufactured at the facility. Conventionally, batch records were paper-based consuming substantial amount of time, efforts, storage space and human resource. Additionally, due to higher human interference, paper-based manual batch record management is more prone to errors. Subsequently, electronic batch record software has emerged as a viable solution for simplifying the overall record management with minimized errors.

One of the most prominent factors driving the electronic batch records software market is the consistently growing adoption of process automation across different industry verticals. Due to growing emphasis on effective quality management, several healthcare organizations have embraced automated software solutions that facilitates seamless process control. With growing power of computing, efficient quality management software have evolved coupled with minimized cost of digital storage. This has significantly encouraged different organizations to shift to electronic quality management solutions (such as EBR). Some of the major advantages of using EBR are as listed below:

  • Enhanced visibility through processes
  • Reduced inventory wastage
  • Improved accuracy and consistency
  • Reduced data entry errors
  • Substantial return on investment
  • Reduced cycle time
  • Better compliance with the regulations
  • Improved decision making
  • Reduced operating costs

The overall electronic batch records software market is categorized on the basis of deployment model, end-user and geographic regions. On the basis of deployment model, the EBR market is segmented into on-premise and hosted EBR. Based on its end-users, the market is categorized into pharmaceuticals, biotechnology, food & beverages, chemicals & polymers, consumer products and others (oil & gas, automobile etc.). In 2016, the overall EBR software market worldwide was led by pharmaceuticals segment accounting for more than 40% of the global market value. Stringent regulations enforced on pharmaceutical companies for effective quality management is the prime factor supporting the segment growth. Geographically, the market was led by North America with market share of more than 1/3rd of the global market value, in 2016.

Some of the major players operating in the market include Siemens AG, Sparta Systems, Inc., QUMAS, SAP SE, Emerson Electric Company, Oracle Corporation, MAXLife Life Sciences Software, MasterControl, Inc., Honeywell International, Inc., Schneider Electric SE, ABB Ltd., Accelrys, Inc., Werum IT Solutions GmbH, Deem Sensing Technologies Pvt. Ltd., MetricStream, Inc., LZ Lifescience and others.

Why was the report written?

This report is the result of an extensive survey drawn from Credence Research’s exclusive panel of leading global market industry executives; it provides data and analysis on buyer investment, acquisition, and developments within the global market research. It includes key topics such as global Sterile Injectables buyer expenditure and procurement behaviors and strategies and recognizes the threats and possibilities within the industry, economic outlook trends, and business confidence within global industry executives. Most secondary research reports are based on general industry drivers and do not understand the industry executives’ attitude and changing behaviors, creating a gap in presenting the business outlook of the industry; in an effort to bridge this gap, Credence Research created this primary research-based report by gathering the opinions of multiple stakeholders in the value chain of the global industry.

What is the current market landscape and what is changing?

Executives from the global industry anticipate an increase in levels of consolidation, with 55% of respondents projecting an increase in merger and acquisition (M&A) activities in 2017.

The report on the market of Electronic Batch Record (EBR) Software contains:

Analysis and forecast of Sterile Injectables market dynamics;

Analysis of domestic production, market shares of the main market players;

Analysis of exports and imports;

Analysis of factors, leading the development of the Sterile Injectables market;

Assessment and forecast of Sterile Injectables market development;

Financial and business profiles of the leading companies in the Sterile Injectables industry.

Scope

– Up to date working Sterile Injectables data by major regions in the world, the forecast of planned capacity additions by 2026

– The annual breakdown of capital expenditure spending on proposed Sterile Injectables for the period 2018 to 2026

– Planned Sterile Injectables additions and capital expenditure spending by key countries and companies across the world

– Planned capital expenditure spending on new Sterile Injectables projects by region, key countries, and companies

– Details of major planned Sterile Injectables projects in the world up to 2026

Also you can request us for sample in pdf with more details and graph: https://www.credenceresearch.com/sample-request/58833

About Us

Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we’ve manufactured a firm extraordinarily prepared to this task.

Contact Us:

Credence Research Inc.

105 N 1st ST #429

SAN JOSE

CA 95103

United States

Toll Free (US/CANADA): +1-800-361-8290

Web: https://www.credenceresearch.com

Leave a Reply

Your email address will not be published. Required fields are marked *